MDMA (3,4-methylenedioxymethamphetamine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MDMA (3,4-methylenedioxymethamphetamine), covering 2021-09-16 to 2021-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) [Phase 3]